世界の持続的腎代替療法市場2023-2030:製品別(システム、消耗品)、モダリティ別、地域別

【英語タイトル】Continuous Renal Replacement Therapy Market Size, Share & Trends Analysis Report By Product (System, Consumables), By Modality, By Region, And Segment Forecasts, 2023 - 2030

Grand View Researchが出版した調査資料(GRV23NOV083)・商品コード:GRV23NOV083
・発行会社(調査会社):Grand View Research
・発行日:2023年9月
・ページ数:110
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:医療
◆販売価格オプション(消費税別)
Single UserUSD5,950 ⇒換算¥904,400見積依頼/購入/質問フォーム
Multi User/Five UserUSD6,950 ⇒換算¥1,056,400見積依頼/購入/質問フォーム
Global/corporate LicenseUSD8,950 ⇒換算¥1,360,400見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・送付(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
❖ レポートの概要 ❖

持続的腎代替療法市場の成長と動向
Grand View Research社の最新レポートによると、世界の持続的腎代替療法市場規模は2030年までに22,603.8百万米ドルに達すると予測されています。同市場は2023年から2030年にかけて年平均成長率8.6%で拡大する見込みです。市場成長の主な推進要因は、うっ血性心不全と急性腎不全の有病率の増加です。COVID-19は、急性腎不全の有病率の増加により、市場に好影響を与えると期待されています。WHOによると、急性腎障害は腎臓が機能しなくなり、尿毒症や体液毒素が体内に蓄積する、生命を脅かす可能性のある病態で、COVID-19の多くの副作用の1つです。その結果、COVID-19の流行が拡大するにつれて、CRRTの需要は増加し続けるでしょう。

予測期間中、技術の進歩は市場成長の重要な原動力になると予想されます。例えば、2020年8月、急性期医療の世界的リーダーであるBaxter International Inc.,は、同社の体外循環路局所クエン酸塩抗凝固用クエン酸塩含有置換液Regiocitが米国食品医薬品局(FDA)から緊急使用許可(EUA)を取得したと発表しました。EUAによると、レジオシットは、COVID-19パンデミックの間、持続的腎代替療法(CRRT)を受けており、局所クエン酸塩抗凝固療法を必要とする成人患者における補充液としての使用に限定して承認されています。

持続的腎代替療法市場レポートハイライト

- 製品別では、消耗品セグメントが2022年に60.6%の最大売上シェアを獲得しました。これらの製品は低価格ですが、繰り返し購入され使用されるため、消耗品市場は他のセグメントと比較して最大です。

- モダリティ別では、持続的静脈内血液濾過(CVVH)部門が2022年に31.6%の最大売上シェアを獲得しました。重症治療室の急性腎障害患者によく見られる体液過多の状況は増加すると予想され、CVVH市場の成長を後押ししました。

- 持続的腎代替療法市場はアジア太平洋地域が9.8%の成長率で急成長しました。この地域の成長には、技術の進歩、医療インフラの発展、巨大な患者基盤の存在など、さまざまな要因が関係しています。

第1章 調査方法・範囲
第2章 エグゼクティブサマリー
第3章 世界の持続的腎代替療法市場変数・傾向・範囲
第4章 世界の持続的腎代替療法市場:製品別予測・傾向分析
第5章 世界の持続的腎代替療法市場:モダリティクラス別予測・傾向分析
第6章 世界の持続的腎代替療法市場:地域別予測・傾向分析
第7章 競争状況

グローバル市場調査レポート販売サイトのwww.marketreport.jpです。

❖ レポートの目次 ❖

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Product
1.1.2. Modality
1.1.3. Regional scope
1.1.4. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. Modality outlook
2.2.3. Regional outlook
2.3. Competitive Insights
Chapter 3. Continuous Renal Replacement Therapy Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Market Dynamics
3.3.1. Market driver analysis
3.3.2. Market restraint analysis
3.4. Continuous Renal Replacement Therapy Market Analysis Tools
3.4.1. Industry Analysis – Porter’s
3.4.1.1. Supplier power
3.4.1.2. Buyer power
3.4.1.3. Substitution threat
3.4.1.4. Threat of new entrant
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Technological landscape
3.4.2.3. Economic landscape
Chapter 4. Continuous Renal Replacement Therapy Market: Product Estimates & Trend Analysis
4.1. Continuous Renal Replacement Therapy Market: Key Takeaways
4.2. Continuous Renal Replacement Therapy Market: Movement & Market Share Analysis, 2022 & 2030
4.3. System
4.3.1. System market estimates and forecasts, 2018 to 2030 (USD Million)
4.4. Consumables
4.4.1. Consumables market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 5. Continuous Renal Replacement Therapy Market: Modality Class Estimates & Trend Analysis
5.1. Continuous Renal Replacement Therapy Market: Key Takeaways
5.2. Continuous Renal Replacement Therapy Market: Movement & Market Share Analysis, 2022 & 2030
5.3. Slow Continuous Ultra-Filtration (SCUF)
5.3.1. Slow continuous ultra-filtration market estimates and forecasts, 2018 to 2030 (USD Million)
5.4. Continuous Venovenous Hemofiltration (CVVH)
5.4.1. Continuous venovenous hemofiltration (CVVH) market estimates and forecasts, 2018 to 2030 (USD Million)
5.5. Continuous Venovenous Hemodialysis (CVVHD)
5.5.1. Continuous venovenous hemodialysis (CVVHD) market estimates and forecasts, 2018 to 2030 (USD Million)
5.6. Continuous Venovenous Hemodiafiltration (CVVHDF)
5.6.1. Continuous venovenous hemodiafiltration (CVVHDF) market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 6. Continuous Renal Replacement Therapy Market: Regional Estimates & Trend Analysis
6.1. Regional Outlook
6.2. Continuous Renal Replacement Therapy Market by Region: Key Takeaways
6.3. North America
6.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.3.2. U.S.
6.3.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.3.3. Canada
6.3.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.4. Europe
6.4.1. U.K.
6.4.1.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.4.2. Germany
6.4.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.4.3. France
6.4.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.4.4. Italy
6.4.4.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.4.5. Spain
6.4.5.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.4.6. Sweden
6.4.6.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.4.7. Norway
6.4.7.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.4.8. Denmark
6.4.8.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.5. Asia Pacific
6.5.1. Japan
6.5.1.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.5.2. China
6.5.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.5.3. India
6.5.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.5.4. Australia
6.5.4.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.5.5. Thailand
6.5.5.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.5.6. South Korea
6.5.6.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.6. Latin America
6.6.1. Brazil
6.6.1.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.6.2. Mexico
6.6.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.6.3. Argentina
6.6.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.7. MEA
6.7.1. Saudi Arabia
6.7.1.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.7.2. South Africa
6.7.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.7.3. UAE
6.7.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.7.4. Kuwait
6.7.4.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis, By Key Participants
7.2. Market Participant Categorization
7.2.1. B. BRAUN MELSUNGEN AG
7.2.1.1. Company overview
7.2.1.2. Financial performance
7.2.1.3. Product benchmarking
7.2.1.4. Strategic initiatives
7.2.2. BAXTER INTERNATIONAL, INC.
7.2.2.1. Company overview
7.2.2.2. Financial performance
7.2.2.3. Product benchmarking
7.2.2.4. Strategic initiatives
7.2.3. FRESENIUS MEDICAL CARE AG & CO. KGAA
7.2.3.1. Company overview
7.2.3.2. Financial performance
7.2.3.3. Product benchmarking
7.2.3.4. Strategic initiatives
7.2.4. ASAHI KASEI CORPORATION
7.2.4.1. Company overview
7.2.4.2. Financial performance
7.2.4.3. Product benchmarking
7.2.4.4. Strategic initiatives
7.2.5. NIPRO CORPORATION
7.2.5.1. Company overview
7.2.5.2. Financial performance
7.2.5.3. Product benchmarking
7.2.5.4. Strategic initiatives
7.2.6. TORAY MEDICAL CO., LTD.
7.2.6.1. Company overview
7.2.6.2. Financial performance
7.2.6.3. Product benchmarking
7.2.6.4. Strategic initiatives
7.2.7. NXSTAGE MEDICAL, INC
7.2.7.1. Company overview
7.2.7.2. Financial performance
7.2.7.3. Product benchmarking
7.2.7.4. Strategic initiatives
7.2.8. MEDTRONIC PLC
7.2.8.1. Company overview
7.2.8.2. Financial performance
7.2.8.3. Product benchmarking
7.2.8.4. Strategic initiatives

List of Tables

Table 1 List of abbreviation
Table 2 North America continuous renal replacement therapy market, by product, 2018 - 2030 (USD Million)
Table 3 North America continuous renal replacement therapy market, by modality, 2018 - 2030 (USD Million)
Table 4 North America continuous renal replacement therapy market, by region, 2018 - 2030 (USD Million)
Table 5 U.S. continuous renal replacement therapy market, by product, 2018 - 2030 (USD Million)
Table 6 U.S. continuous renal replacement therapy market, by modality, 2018 - 2030 (USD Million)
Table 7 Canada continuous renal replacement therapy market, by product, 2018 - 2030 (USD Million)
Table 8 Canada continuous renal replacement therapy market, by modality, 2018 - 2030 (USD Million)
Table 9 Europe continuous renal replacement therapy market, by product, 2018 - 2030 (USD Million)
Table 10 Europe continuous renal replacement therapy market, by modality, 2018 - 2030 (USD Million)
Table 11 Europe continuous renal replacement therapy market, by region, 2018 - 2030 (USD Million)
Table 12 Germany continuous renal replacement therapy market, by product, 2018 - 2030 (USD Million)
Table 13 Germany continuous renal replacement therapy market, by modality, 2018 - 2030 (USD Million)
Table 14 UK continuous renal replacement therapy market, by product, 2018 - 2030 (USD Million)
Table 15 UK continuous renal replacement therapy market, by modality, 2018 - 2030 (USD Million)
Table 16 France continuous renal replacement therapy market, by product, 2018 - 2030 (USD Million)
Table 17 France continuous renal replacement therapy market, by modality, 2018 - 2030 (USD Million)
Table 18 Italy continuous renal replacement therapy market, by product, 2018 - 2030 (USD Million)
Table 19 Italy continuous renal replacement therapy market, by modality, 2018 - 2030 (USD Million)
Table 20 Spain continuous renal replacement therapy market, by product, 2018 - 2030 (USD Million)
Table 21 Spain continuous renal replacement therapy market, by modality, 2018 - 2030 (USD Million)
Table 22 Sweden continuous renal replacement therapy market, by product, 2018 - 2030 (USD Million)
Table 23 Sweden continuous renal replacement therapy market, by modality, 2018 - 2030 (USD Million)
Table 24 Norway continuous renal replacement therapy market, by product, 2018 - 2030 (USD Million)
Table 25 Norway continuous renal replacement therapy market, by modality, 2018 - 2030 (USD Million)
Table 26 Denmark continuous renal replacement therapy market, by product, 2018 - 2030 (USD Million)
Table 27 Denmark continuous renal replacement therapy market, by modality, 2018 - 2030 (USD Million)
Table 28 Asia Pacific continuous renal replacement therapy market, by product, 2018 - 2030 (USD Million)
Table 29 Asia Pacific continuous renal replacement therapy market, by modality, 2018 - 2030 (USD Million)
Table 30 Asia Pacific continuous renal replacement therapy market, by region, 2018 - 2030 (USD Million)
Table 31 Japan continuous renal replacement therapy market, by product, 2018 - 2030 (USD Million)
Table 32 Japan continuous renal replacement therapy market, by modality, 2018 - 2030 (USD Million)
Table 33 China continuous renal replacement therapy market, by product, 2018 - 2030 (USD Million)
Table 34 China continuous renal replacement therapy market, by modality, 2018 - 2030 (USD Million)
Table 35 India continuous renal replacement therapy market, by product, 2018 - 2030 (USD Million)
Table 36 India continuous renal replacement therapy market, by modality, 2018 - 2030 (USD Million)
Table 37 Australia continuous renal replacement therapy market, by product, 2018 - 2030 (USD Million)
Table 38 Australia continuous renal replacement therapy market, by modality, 2018 - 2030 (USD Million)
Table 39 Thailand continuous renal replacement therapy market, by product, 2018 - 2030 (USD Million)
Table 40 Thailand continuous renal replacement therapy market, by modality, 2018 - 2030 (USD Million)
Table 41 South Korea continuous renal replacement therapy market, by product, 2018 - 2030 (USD Million)
Table 42 South Korea continuous renal replacement therapy market, by modality, 2018 - 2030 (USD Million)
Table 43 Latin America continuous renal replacement therapy market, by product, 2018 - 2030 (USD Million)
Table 44 Latin America continuous renal replacement therapy market, by modality, 2018 - 2030 (USD Million)
Table 45 Latin America continuous renal replacement therapy market, by region, 2018 - 2030 (USD Million)
Table 46 Brazil continuous renal replacement therapy market, by product, 2018 - 2030 (USD Million)
Table 47 Brazil continuous renal replacement therapy market, by modality, 2018 - 2030 (USD Million)
Table 48 Mexico continuous renal replacement therapy market, by product, 2018 - 2030 (USD Million)
Table 49 Mexico continuous renal replacement therapy market, by modality, 2018 - 2030 (USD Million)
Table 50 Argentina continuous renal replacement therapy market, by product, 2018 - 2030 (USD Million)
Table 51 Argentina continuous renal replacement therapy market, by modality, 2018 - 2030 (USD Million)
Table 52 Middle East and Africa continuous renal replacement therapy market, by product, 2018 - 2030 (USD Million)
Table 53 Middle East and Africa continuous renal replacement therapy market, by modality, 2018 - 2030 (USD Million)
Table 54 Middle East and Africa continuous renal replacement therapy market, by region, 2018 - 2030 (USD Million)
Table 55 South Africa continuous renal replacement therapy market, by product, 2018 - 2030 (USD Million)
Table 56 South Africa continuous renal replacement therapy market, by modality, 2018 - 2030 (USD Million)
Table 57 Saudi Arabia continuous renal replacement therapy market, by product, 2018 - 2030 (USD Million)
Table 58 Saudi Arabia continuous renal replacement therapy market, by modality, 2018 - 2030 (USD Million)
Table 59 UAE continuous renal replacement therapy market, by product, 2018 - 2030 (USD Million)
Table 60 UAE continuous renal replacement therapy market, by modality, 2018 - 2030 (USD Million)
Table 61 Kuwait continuous renal replacement therapy market, by product, 2018 - 2030 (USD Million)
Table 62 Kuwait continuous renal replacement therapy market, by modality, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Continuous renal replacement therapy: market outlook
Fig. 9 Continuous renal replacement therapy competitive insights
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook
Fig. 12 Penetration and growth prospect mapping
Fig. 13 Industry value chain analysis
Fig. 14 Continuous renal replacement therapy market driver impact
Fig. 15 Continuous renal replacement therapy market restraint impact
Fig. 16 Continuous renal replacement therapy market strategic initiatives analysis
Fig. 17 Continuous renal replacement therapy market: Product movement analysis
Fig. 18 Continuous renal replacement therapy market: Product outlook and key takeaways
Fig. 19 System market estimates and forecasts, 2018 - 2030
Fig. 20 Consumables market estimates and forecasts, 2018 - 2030
Fig. 21 Continuous renal replacement therapy market: Modality class outlook movement analysis
Fig. 22 Continuous renal replacement therapy market: Modality class outlook and key takeaways
Fig. 23 Slow continuous ultra-filtration market (SCUF) estimates and forecasts, 2018 - 2030
Fig. 24 Continuous venovenous hemofiltration (CVVH) market estimates and forecasts, 2018 - 2030
Fig. 25 Continuous venovenous hemodialysis (CVVHD) market estimates and forecasts, 2018 - 2030
Fig. 26 Continuous venovenous hemodiafiltration (CVVHDF) market estimates and forecasts, 2018 - 2030
Fig. 27 Continuous renal replacement therapy market: Regional movement analysis
Fig. 28 Continuous renal replacement therapy market: Regional outlook and key takeaways
Fig. 29 North America market estimates and forecasts, 2018 - 2030
Fig. 30 U.S. market estimates and forecasts, 2018 - 2030
Fig. 31 Canada market estimates and forecasts, 2018 - 2030
Fig. 32 Europe market estimates and forecasts, 2018 - 2030
Fig. 33 UK market estimates and forecasts, 2018 - 2030
Fig. 34 Germany market estimates and forecasts, 2018 - 2030
Fig. 35 France market estimates and forecasts, 2018 - 2030
Fig. 36 Italy market estimates and forecasts, 2018 - 2030
Fig. 37 Spain market estimates and forecasts, 2018 - 2030
Fig. 38 Sweden market estimates and forecasts, 2018 - 2030
Fig. 39 Norway market estimates and forecasts, 2018 - 2030
Fig. 40 Denmark market estimates and forecasts, 2018 - 2030
Fig. 41 Asia Pacific market estimates and forecasts, 2018 - 2030
Fig. 42 Japan market estimates and forecasts, 2018 - 2030
Fig. 43 China market estimates and forecasts, 2018 - 2030
Fig. 44 India market estimates and forecasts, 2018 - 2030
Fig. 45 Australia market estimates and forecasts, 2018 - 2030
Fig. 46 Thailand market estimates and forecasts, 2018 - 2030
Fig. 47 South Korea market estimates and forecasts, 2018 - 2030
Fig. 48 Latin America market estimates and forecasts, 2018 - 2030
Fig. 49 Brazil market estimates and forecasts, 2018 - 2030
Fig. 50 Mexico market estimates and forecasts, 2018 - 2030
Fig. 51 Argentina market estimates and forecasts, 2018 - 2030
Fig. 52 Middle East and Africa. market estimates and forecasts, 2018 - 2030
Fig. 53 Saudi Arabia market estimates and forecasts, 2018 - 2030
Fig. 54 South Africa market estimates and forecasts, 2018 - 2030
Fig. 55 UAE market estimates and forecasts, 2018 - 2030
Fig. 56 Kuwait market estimates and forecasts, 2018 - 2030

★調査レポート[世界の持続的腎代替療法市場2023-2030:製品別(システム、消耗品)、モダリティ別、地域別] (コード:GRV23NOV083)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の持続的腎代替療法市場2023-2030:製品別(システム、消耗品)、モダリティ別、地域別]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆